Clinical Trial
doi: 10.1023/a:1005548619694.Efficacy of methylphenidate among children with autism and symptoms of attention-deficit hyperactivity disorder
Affiliations
- PMID:11055460
- DOI: 10.1023/a:1005548619694
Item in Clipboard
Clinical Trial
Efficacy of methylphenidate among children with autism and symptoms of attention-deficit hyperactivity disorder
B L Handen et al. J Autism Dev Disord.2000 Jun.
Display options
Format
Display options
Format
Abstract
Thirteen children (ages 5.6 to 11.2 years) with autism and symptoms of attention-deficit hyperactivity disorder (ADHD) participated in a double-blind, placebo-controlled crossover study of methylphenidate (0.3 and 0.6 mg/kg per dose). Eight subjects responded positively, based upon a minimum 50% decrease on the Conners Hyperactivity Index. Ratings of stereotypy and inappropriate speech, which are often associated with autistic core features, also decreased. However, no changes were found on the Child Autism Rating Scale, a global assessment of autistic symptomotology. Significant adverse side effects occurred in some children including social withdrawal and irritability, especially at the 0.6 mg/kg dose. Results suggest that methylphenidate can be efficacious for children with autism and ADHD symptoms. However, this group of children seems to be particularly susceptible to adverse side effects.
Similar articles
- A dose-response study of OROS methylphenidate in children with attention-deficit/hyperactivity disorder.Stein MA, Sarampote CS, Waldman ID, Robb AS, Conlon C, Pearl PL, Black DO, Seymour KE, Newcorn JH.Stein MA, et al.Pediatrics. 2003 Nov;112(5):e404. doi: 10.1542/peds.112.5.e404.Pediatrics. 2003.PMID:14595084Clinical Trial.
- Short-term side effects of stimulant medication are increased in preschool children with attention-deficit/hyperactivity disorder: a double-blind placebo-controlled study.Firestone P, Musten LM, Pisterman S, Mercer J, Bennett S.Firestone P, et al.J Child Adolesc Psychopharmacol. 1998;8(1):13-25. doi: 10.1089/cap.1998.8.13.J Child Adolesc Psychopharmacol. 1998.PMID:9639076Clinical Trial.
- Efficacy of a novel biphasic controlled-release methylphenidate formula in adults with attention-deficit/hyperactivity disorder: results of a double-blind, placebo-controlled crossover study.Jain U, Hechtman L, Weiss M, Ahmed TS, Reiz JL, Donnelly GA, Harsanyi Z, Darke AC.Jain U, et al.J Clin Psychiatry. 2007 Feb;68(2):268-77. doi: 10.4088/jcp.v68n0213.J Clin Psychiatry. 2007.PMID:17335326Clinical Trial.
- Immediate-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults.Epstein T, Patsopoulos NA, Weiser M.Epstein T, et al.Cochrane Database Syst Rev. 2014 Sep 18;(9):CD005041. doi: 10.1002/14651858.CD005041.pub2.Cochrane Database Syst Rev. 2014.Update in:Cochrane Database Syst Rev. 2016 May 26;(5):CD005041. doi: 10.1002/14651858.CD005041.pub3.PMID:25230710Updated.Review.
- [Efficacy and safety of stimulants and non-stimulants in adults with attention deficit hyperactivity disorder (ADHD)].Golubchik P, Sever J, Weizman A.Golubchik P, et al.Harefuah. 2011 Oct;150(10):788-90, 814.Harefuah. 2011.PMID:22111124Review.Hebrew.
Cited by
- Treatment of Autism Spectrum Disorder in Children and Adolescents.DeFilippis M, Wagner KD.DeFilippis M, et al.Psychopharmacol Bull. 2016 Aug 15;46(2):18-41.Psychopharmacol Bull. 2016.PMID:27738378Free PMC article.
- Assessment and treatment in autism spectrum disorders: a focus on genetics and psychiatry.Butler MG, Youngs EL, Roberts JL, Hellings JA.Butler MG, et al.Autism Res Treat. 2012;2012:242537. doi: 10.1155/2012/242537. Epub 2012 May 31.Autism Res Treat. 2012.PMID:22934170Free PMC article.
- Analysis of WISC-III, Stanford-Binet:IV, and academic achievement test scores in children with autism.Mayes SD, Calhoun SL.Mayes SD, et al.J Autism Dev Disord. 2003 Jun;33(3):329-41. doi: 10.1023/a:1024462719081.J Autism Dev Disord. 2003.PMID:12908835
- Atomoxetine and Parent Training for Children With Autism and Attention-Deficit/Hyperactivity Disorder: A 24-Week Extension Study.Smith T, Aman MG, Arnold LE, Silverman LB, Lecavalier L, Hollway J, Tumuluru R, Hyman SL, Buchan-Page KA, Hellings J, Rice RR Jr, Brown NV, Pan X, Handen BL.Smith T, et al.J Am Acad Child Adolesc Psychiatry. 2016 Oct;55(10):868-876.e2. doi: 10.1016/j.jaac.2016.06.015. Epub 2016 Aug 2.J Am Acad Child Adolesc Psychiatry. 2016.PMID:27663942Free PMC article.Clinical Trial.
- [Psychopharmacology of autism spectrum disorders].Poustka L, Banaschewski T, Poustka F.Poustka L, et al.Nervenarzt. 2011 May;82(5):582-9. doi: 10.1007/s00115-010-3238-7.Nervenarzt. 2011.PMID:21484169Review.German.
References
Publication types
MeSH terms
Substances
Related information
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical